Home Cart Sign in  
Chemical Structure| 3420-72-2 Chemical Structure| 3420-72-2

Structure of Flavokawain A
CAS No.: 3420-72-2

Chemical Structure| 3420-72-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Flavokawain A, a natural product isolated and purified from the roots of Piper methysticum with anti-tumor and anti-inflammatory activities, can significantly reduce the expression of CDK1-inhibitory kinases, Myt1 and Wee1, and cause cyclin B1 protein accumulation leading to CDK1 activation in T24 cells.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Flavokawain A

CAS No. :3420-72-2
Formula : C18H18O5
M.W : 314.33
SMILES Code : O=C(C1=C(OC)C=C(OC)C=C1O)/C=C/C2=CC=C(OC)C=C2
MDL No. :MFCD00017174

Safety of Flavokawain A

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Syo-I 10 μg/ml 24 or 72 hours Inhibition of cell proliferation and invasion Transl Oncol. 2020 Oct;13(10):100809
Hssy-II 10 μg/ml 24 or 72 hours Inhibition of cell proliferation and invasion Transl Oncol. 2020 Oct;13(10):100809
T24 40 μM different times FKA inhibits PRMT5 expression, thereby inhibiting the growth and inducing apoptosis of bladder cancer cells. J Exp Clin Cancer Res. 2022 Oct 5;41(1):293
UMUC3 40 μM different times FKA inhibits PRMT5 expression, thereby inhibiting the growth and inducing apoptosis of bladder cancer cells. J Exp Clin Cancer Res. 2022 Oct 5;41(1):293
mouse chondrocytes 20 μM and 40 μM 24 hours To evaluate the effect of FKA on inflammation and metabolism in chondrocytes. FKA reduced the expression of inflammatory factors (COX2 and iNOS) and catabolic enzymes (ADAMTS5 and MMPs), and upregulated the expression of anabolic proteins (Col2, Aggrecan, and SOX9). Front Bioeng Biotechnol. 2022 Dec 5;10:1071776
MCF10A >100 μM 72 hours FKA has minimal effect on the growth of non-malignant breast epithelial cells. Molecules. 2017 Mar 14;22(3):462
MDA-MB-468 45 μM 24 hours FKA inhibits cell growth. Molecules. 2017 Mar 14;22(3):462
MCF7 38.4 μM 24 hours FKA induces G1 arrest. Molecules. 2017 Mar 14;22(3):462
MCF7/HER2 13.6 μM 24 hours FKA induces G2M arrest by inhibiting phosphorylation of Cdc2 and Cdc25C, downregulating expression of Myt1 and Wee1, and increasing Cdc2 kinase activity. Molecules. 2017 Mar 14;22(3):462
SKBR3 10 μM 24 hours FKA induces G2M arrest by inhibiting phosphorylation of Cdc2 and Cdc25C, downregulating expression of Myt1 and Wee1, and increasing Cdc2 kinase activity. Additionally, FKA induces apoptosis in SKBR3 cells by increasing protein expression of Bim and BAX and decreasing expression of Bcl-2, Bcl-X/L, XIAP, and survivin. Molecules. 2017 Mar 14;22(3):462
STC-1 cells 100 μM 1 hour stimulated GLP-1 secretion and inhibited DPP-4 enzyme activity Pharmaceuticals (Basel). 2022 Dec 12;15(12):1543
B16/F10 melanoma cells 25 µM 72 hours To evaluate cytotoxicity and melanogenesis inhibition, results showed FLA at 25 µM significantly reduced melanin content and tyrosinase activity Molecules. 2020 Jul 28;25(15):3403
HUVECs 5-25 µmol 24 hours To evaluate the protective effect of FKA against OTA-induced endothelial cell injury, results showed that FKA significantly inhibited OTA-induced apoptosis and oxidative stress. Toxins (Basel). 2021 Oct 21;13(11):745
HepG2 50 μM 24 h To test for subsequent resistance to oxidative stress, FKA pretreatment mitigated cell death after a subsequent challenge with H2O2, being similar to SFN. Pharm Biol. 2016 Sep;54(9):1503-12
HepG2 2–100 μM 24–48 h To assess the toxicity of FKA and FKB in HepG2 cells, FKA (≤100μM) was not toxic to HepG2, whereas FKB caused significant cell death (IC50=23.2±0.8μM). Pharm Biol. 2016 Sep;54(9):1503-12
A7r5 cells 2-30 μM 24 hours To evaluate the anti-fibrotic and antioxidant properties of FKA in TGF-β1-stimulated A7r5 cells. Results showed that FKA treatment suppressed TGF-β1-induced α-SMA and fibronectin expression and inhibited cell migration and invasion. J Cell Mol Med. 2019 Feb;23(2):775-788

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Balb/c nude mice Subcutaneous xenograft model Intraperitoneal injection 30 mg/kg Every 3 days for 24 days FKA significantly inhibited tumor growth, reducing tumor volume and weight. J Exp Clin Cancer Res. 2022 Oct 5;41(1):293
Mice UPII-mutant Ha-ras transgenic mice Oral 6 g/kg food Daily, for 6 months To evaluate the chemopreventive efficacy of FKA against mutant Ha-ras-driven urothelial tumorigenesis. Results showed that FKA significantly increased the survival rate of male mice, reduced bladder weight (tumor burden), and decreased incidences of hydronephrosis and hematuria. Pharmaceutics. 2022 Feb 24;14(3):496
SCID mice Subcutaneous xenograft model Oral 600 mg/kg/day Once daily for 6 weeks Inhibition of tumor growth Transl Oncol. 2020 Oct;13(10):100809
C57BL/6J male mice Destabilization of the medial meniscus (DMM) model Intra-articular injection 50 mg/kg Once weekly for 8 weeks To evaluate the therapeutic effect of FKA on OA mice. FKA significantly reduced cartilage damage and increased the expression of Aggrecan and Col2. Front Bioeng Biotechnol. 2022 Dec 5;10:1071776
Zebrafish (Danio rerio) IBMX-induced melanogenesis model Dissolved in embryo media 25 µM From 9 hpf to 144 hpf To assess toxicity and melanogenesis inhibition, results showed FLA at 25 μM was non-toxic and effectively inhibited melanogenesis Molecules. 2020 Jul 28;25(15):3403

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.18mL

0.64mL

0.32mL

15.91mL

3.18mL

1.59mL

31.81mL

6.36mL

3.18mL

References

 

Historical Records

Categories